MDXG - MiMedx Fixes Cash Concerns With Relisting Right Around The Corner

MiMedx Group Inc. (MDXG) has finally come through for shareholders as it is now caught up on financial reporting. Audited results help to deflate much of the short thesis as a new executive team and Board initiate the process for relisting the company on the Nasdaq. Organizing and growing the company's sales force for its best-in-class products will take some ingenuity during COVID-19, but progress there and in its clinical candidates could produce fruit in 2020 and 2021. A recent capital raise is the cherry on top as the company now has the resources to

Read more ...